MMCAP International’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

MMCAP International’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-800,000	Closed	-$8.18M	–	265
2023 Q1	$8.18M	Hold	800,000	–	–	1.61%	17
2022 Q4	$8.04M	Hold	800,000	–	–	0.82%	35
2022 Q3	$7.87M	Hold	800,000	–	–	0.62%	45
2022 Q2	$7.79M	Hold	800,000	–	–	0.62%	43
2022 Q1	$7.79M	Hold	800,000	–	–	0.46%	71
2021 Q4	$7.74M	Hold	800,000	–	–	0.48%	67
2021 Q3	$7.86M	Buy	+800,000	New	+$7.81M	0.55%	64

MMCAP International's ORIA Position: Q2 2023 in Review

MMCAP International sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 800,000 shares — an estimated $8.18M sold.

MMCAP International first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $8.18M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

MMCAP International reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
MMCAP International sold 800,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $8.18M.
MMCAP International first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
MMCAP International's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $8.18M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on MMCAP International's 13F filing for Q2 2023, filed 14 Aug 2023.